Evidence map›Paper›PMID 25488098›Full record

ArticleBMJ open2014

Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important.

Sara S McMillan, Fiona Kelly, Adem Sav, Michelle A King, Jennifer A Whitty, Amanda J Wheeler

Abstract read
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Article
  3. Article
  4. The landscape of self-care in Australia: A pharmacy perspective.Exploratory research in clinical and social pharmacy · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pharmacist-led minor ailment programs: a Canadian perspective.International journal of general medicine · 2016
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara S McMillanGriffith Health Institute, Griffith University, Meadowbrook, Queensland, Australia Griffith Health Institute, School of Pharmacy, Griffith University, Southport, Queensland, Australia.
Fiona KellyGriffith Health Institute, Griffith University, Meadowbrook, Queensland, Australia School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Adem SavGriffith Health Institute, Griffith University, Meadowbrook, Queensland, Australia School of Allied Health, Australian Catholic University, Banyo, Queensland, Australia.
Michelle A KingGriffith Health Institute, School of Pharmacy, Griffith University, Southport, Queensland, Australia.
Jennifer A WhittyGriffith Health Institute, Griffith University, Meadowbrook, Queensland, Australia School of Pharmacy, University of Queensland, Woolloongabba, Queensland, Australia.
Amanda J WheelerGriffith Health Institute, Griffith University, Meadowbrook, Queensland, Australia School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the purpose/s for which people with chronic conditions and their carers use Australian community pharmacies, and compare this to what pharmacy services they consider important, from the perspectives of both consumers and pharmacists.

designAn exploratory study involving a survey, which asked participants to indicate the pharmacy services they had ever used, and rate the importance of 22 pharmacy services to them, or the person they care for, or for their consumers if a pharmacist.

settingFour regions of Australia: Logan-Beaudesert and Mt Isa/North West region, Queensland, Northern Rivers, New South Wales, and the Greater Perth area, Western Australia.

participantsSurveys were undertaken with 602 consumers and 91 community pharmacists.

resultsCommunity pharmacy is predominantly used to obtain advice about medication and whether a doctor's visit is necessary, as well as for monitoring and screening services. Pharmacy services that were patient centric were important, such as individualised medication advice and respectful care, as well as tools or procedures to facilitate streamlined medication access. Less important services included adult vaccinations and health and wellness programmes. Carers identified services that assisted them with their specific role/s to be important. Overall, community pharmacists had a good understanding of the services that were important to people with chronic conditions and their carers.

conclusionsPeople with chronic conditions and their carers not only care about what services are delivered, but how they are delivered; they sought services that generally improved their access to medication and information, but in a way that was patient centred. Ultimately, pharmacists understood the importance of patient-centred care for people with chronic conditions and their carers, perhaps indicating a greater acceptance of integrating patient-centred care into their everyday practice.

Indexed as

Medication AdherencePopulation SurveillanceProfessional RoleAdolescentAdultAgedAged, 80 and overAustraliaCaregiversChronic DiseaseCommunity Pharmacy ServicesDelivery of Health CareFemaleHumansMaleMiddle Agedchronic diseasecommunity pharmacypatient-centered carepharmacists

Identifiers

PMID25488098
PMCPMC4265097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.